Partnership Expansion Surescripts has recently expanded partnerships with Elation Health, Psychiatry-Cloud, and WRS Health, indicating a growing focus on collaborating with healthcare technology companies. Leveraging these partnerships can open the door to cross-selling opportunities and tapping into new client bases.

Acquisition Strategy By acquiring ActiveRADAR, Surescripts shows an interest in enhancing its offerings related to therapeutic alternatives for prescription drugs. This acquisition presents a chance for sales teams to propose integrated solutions that combine ActiveRADAR's capabilities with Surescripts' existing services.

Executive Leadership With the appointment of Lynne Nowak as Chief Data and Analytics Officer, Surescripts demonstrates a strategic investment in data analytics capabilities. Sales professionals can leverage this executive leadership change to pitch data-driven solutions to healthcare organizations looking to enhance their insights and decision-making processes.

Market Compliance Following FTC settlement due to alleged anticompetitive practices, Surescripts has the opportunity to showcase its commitment to market compliance and fair competition. Sales representatives can use this as a talking point to assure potential clients of Surescripts' adherence to industry regulations, building trust and credibility.

Revenue Scale With a revenue ranging between $100M - 1B, Surescripts falls within the bracket of mid to large-sized companies in the healthcare IT industry. Sales development professionals can target organizations of similar revenue scale as potential clients, understanding their financial capacity for investing in advanced health intelligence solutions.